Grifols (GRFS) EBT (QoQ) (2010 - 2020)
Grifols (GRFS) EBT (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.87 Bn | 632.12 Bn | 17.26 Bn |
| 2 | AbbVie | 470.09 Bn | 463.52 Bn | 12.70 Bn |
| 3 | Merck | 375.69 Bn | 368.55 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.40 Bn | 295.71 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.51 Bn | 252.61 Bn | 12.86 Bn |
| 6 | Amgen | 236.27 Bn | 222.28 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.86 Bn | 178.68 Bn | 6.22 Bn |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn |
| 9 | Gsk | 106.16 Bn | 101.99 Bn | 8.24 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -55.09% |
| Mar 31, 2019 | -75.67% |
| Jun 30, 2018 | 42.07% |
| Mar 31, 2018 | -68.36% |
| Jun 30, 2017 | 60.62% |
| Mar 31, 2017 | 777.10% |
| Dec 31, 2016 | -91.67% |
| Sep 30, 2016 | 6.94% |
| Jun 30, 2016 | -34.46% |
| Mar 31, 2016 | 1,353.35% |
| Dec 31, 2015 | -111.06% |
| Sep 30, 2015 | 6.23% |
| Jun 30, 2015 | -3.03% |
| Mar 31, 2015 | 150.23% |
| Dec 31, 2014 | -393.73% |
| Sep 30, 2014 | 98,201.12% |
| Jun 30, 2014 | -99.94% |
| Mar 31, 2014 | 101.43% |
| Dec 31, 2013 | -8.31% |
| Sep 30, 2013 | -5.76% |